Neurohormonal activation, angiogenesis, and heart failure. Clinical and experimental studies by Boer, Rudolf Allert de
  
 University of Groningen
Neurohormonal activation, angiogenesis, and heart failure. Clinical and experimental studies
Boer, Rudolf Allert de
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2002
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Boer, R. A. D. (2002). Neurohormonal activation, angiogenesis, and heart failure. Clinical and experimental
studies. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




SuuvnRv oF THE cHAPTERS The aim of the studies was to investigate: 1) whether
changes in microvasculature, angiogenesis, and angiogenesis factors occur in heart fail-
ure, and affect its outcome and 2) whether neurohormonal correlates can be identified
that modulate these factors, and 3) whether correcrion of the microvascular abnormali-
ties with specific neurohormonal inhibitors is possible. It was shown that changes in mi-
crovasculature, angiogenesis, and angiogenesis factors occur in heart failure, although it
is not established yet whether changes in microvasculature, angiogenesis, and angiogen-
esis factors affect the outcome of heart failure. The second aim yielded data on the im-
pact of neurohormonal parameters, and signaling proteins that confer neurohormonal
activation. \We established that blockade of the Af, receptor, beta-recepror and ERK may
be involved in microvascular abnormalities.
Heart failure is a widespread disease in developed countries with high morbidity and ex-
cess mortality. Historically, heart failure was regarded as a contractile impairment of the
heart muscle, leading to hypoperfusion of the organs, especially upon demand (exercise).
Nowadays, heart failure rather is considered as a clinical syndrome, in which the cardiac
dysfunction is the primary trigger for activation of various counrer-regularory sysrems.
Although on the short term these systems may uphold the circulation, on the long term
they further impede cardiac function, and also adversely affect (remodel) other organ sys-
tems, especially the vasculature and the kidneys.
A specific compartment of the vasculature, the microcirculation, presenrs with distinct
abnormalities in heart failure. The microvasculature consists of small arterioles (beyond
the third order), capillaries and efferent venules. Generally, microvessels with a diameter
of <150 pm are referred to as "microvessels". The abnormalities comprise a decrease in
total number of microvessels, as well as a dysfunction of the remaining endothelium (en-
dothelial dysftrnction).
Although the concept of a contributory role of endothelial dysfunction to cardiac dys-
function is widely accepted, the importance of a deficient microvasculature is contested.
It is not well understood what the role is of various factors that become activated in heart
failure with respect to the growth and maintenance of the microvessels. Factors that are
mitogenic to the endothelium have been isolated, and are thought to play a major role
in the growth of microvessels. Especially vascular endothelial growth factor (VEGF) is a
key factor in microvessel growth (angiogenesis). This factor is secrered by many cells
upon hypoxia.
This thesis addresses issues that may clari$' the presence of microvessel abnormalities.
Specifically, the number of microvessels in (hypertensive) cardiomyopathy and after my-
ocardial infarction was studied. Pharmacological modalities were evaluated for their value
to restore microvessel abnormalities. In chapters I and 2, definitions and terminology are
provided, and aims and scope of the thesis are described. Since heart failure is a syndrome
with a heterogeneous etiology, we discussed in chapter 2 the microvascular abnormalities
that are present in various forms of heart failure. The knowledge that has been accumu-








Some specific forms of cardiac hypertrophy, like exercise- and thyreotoxicosis-induced
left ventricular hypertrophy (LVH), are however accompanied by an increase in mi-
crovessels. Noteworthy, these forms of LVH rarely culminate into heart failure. The ex-
pression patterns of growth factors that mediate microvessel growth have inadequately
been studied. Neurohormonal disarray, an important pathophysiological contributory
f:rctor in heart failure, affects microvascular growth, but the precise interplay between the
rwo is not fully elucidated.
In chapter 3, the expression pattern of VEGF in idiopathic dilated cardiomyopathy
(lDC) was investigated, establishing a down-regulation of VEGF, irrespective of the
severity of the disease was established. Moreover, there seems to be a differential activa-
tion pattern, with a more substantial down-regulation of the smallest VEGF isoform
(VECF,.,),  and a smaller decrease of VEGF,,,,  and VEGF,*,, .  I t  is hypothesized that this
downregulation of VEGF could be associated with the observecl decrease of microvessels
in IDC, and may entai l  a mechanism that, at least in part,  expl:r ins the ischemia-l ike my-
ocardial responses to stress.
ln chapter 4, levels of plasmaVEGF were studied in patients with heart failure, and the
response to treatment with the beta-blocker carvedilol. It was found that plasma levels of
VEGF rise after initiation of beta-blockade. This may reflect increased myocardial VEGF
production in the heart,  possibly due to lowering of the heart rate. Further studies should
delineate whether the ber-reficial effects of beta-blockers in heart failure, but also in
ischernic heart disease, are explained by the upregulation of VEGF and subsequent an-
giogenesis.
To investigate the impact of the renin-angiotensin system (RAS) on microvascular
growth in heart failure, transgenic models were used that overexpress pecific elements of
the RAS. In chapter 5, a model of experimental myocardial infarction (MI) that indr.rces
left ventricular remodeling was studied, and normal rats were compared with transgenic
rats (TGR), that have cardioselective overexpression of the angiotensin II rype I (AT,) re-
ceptor. Part of the rats was treated with the selective AT, receptor blocker losartan. It was
shown that high levels of AT, receptors are associated with low levels of microvessel den-
sity in the non-infarcted, remodeled part of the myocardium. This was amenable to se-
lective AT, receptor blockade. VEGF showed a differential expression pattern in these
rats. Although it was increased after MI, AT, receptors blockade blunted rather than
stimulated VEGF expression. The VEGF expressiorr was increased post-Ml. However, it
was not correlated with ar-r increase in microvessel dcnsity. Hemodyn:rmic alterations and
the level of neurohormonal activation did also not affect VEGF expression. Microvessel
density seemed thus regulared by AT, receptor level, but possibly :rlso by other neuro-
hormonal parameters, and hemodynamics.
Chapter 6 evaluates the mitogen-activatecl protein kinases (MAPKs) pathways that may
rnediate AT, receptor sigr-r:rling, using parameters of LV remodeling as outcorne meas-
ures. For this, another transgenic moclel, the well described REN2 rat (homozygous vari-
ant) was employed. 'l 'his model is homozygous for the expression of the mollse renin-2
gene. This strain has severe end-organ darnage that quickly proceeds into intractable ancl
lethal heart fàilure.'rVe for.rnd that in rhe REN2 rat, the extracellular signal-related kinase
(ERK) is activ:rted, whereas p3B MAPK remains unactivated. Hereafter, the value of in-
r4t
CHAP'I ' I- ]R 9
l ' r ibirors of ERK r 'vas erplored. I t  r ,vas f ixrncl rhar EI{K inhibir ion part ial lr .  lecl ro prever-
t ion of LVH ancl IV clysf irnct ion. l-urthermore, EI{K-inhibit ion 
.,rn.rpl. t . lu preve.rc. l  f i -
brosis, r l trcl  restorecl t t t icrovessel clensity fo irs conrrol values. Contr. l  rrcatr.enr with 41-,
rcccptor blockacie (canclesartatr) wus also able to prcvcnr rhe devckrpnrcnr of calcl iuc clys-
f irr-rct iorr, :rnd L\ i  architcctural changes. l t  is concluclccl rhtrr in thi.s nr6clcl of hyp,cr.rep-
sive hcart fài l trre, F. lLK is act ivatccl ancl F.RK inl ' r ibi t ion prevcrlrs IV rcpoclel ipe. ' l -6is
t lay bc a ccl l-spccifrc act ivat ion, with a rel:r t ive over-acrivation in f lbroblasrs:.rrcl  c.-
c' lothel ial cel ls, si t lcc inhibit ion was csl.rccial ly eff icacious in prevcnring f. ibrosis urcl ' r i -
crovcsscl abnonrrr l i t ies.
f  n chapter 7, rhe cÍ lccrs of Al ' ,  rccepror signal ing r. tn shor.t-te;"zzz ischcrl ia r.r .erc stucl iecl.
Agair l ,  the T(l l{  r-r-roclel rvi th carcl iosclcct ive ovcrexprcssion of rhe A' l ' ,  rccepror wrls cnr-
Ployccl '  l loth with arlcl  rvi thout t l .rc se Icct ive AT, rcccpror blocker losarral.  I '  rhc is. larccl
rr l t  hertrt ,  we stucl ict l  the impact of ischemria-reperf irsion  carcl iac clarn:rge a.cl r .ral
t inre of arrhytl ' rnr irr r lur ing repcrf irsior.t .  I t t-uiuo, wc sttrcl iecl rhe short-terrn cffecrs of MI
b l ' recorc l i t lg  n tor t l t l i t t 'anc i  sc l -L l rn  t roponin .  AI ' ,  recc l - r r ( ) l 'ovcr -cxpr-css i t - r r r  w.s .o t  f i r r r .c l
cletr i t l lct l t l r l  in terl t ts t t f  ci trrart ion of reperf irsion-inclucccl arrhythn,ias, h.rvevcr AI-,  re-
ceptor lr lockade I ir l r i tccl total dltrarion of rcperf irsion-incl lrcec{ arrhytl"rprias, pecif ic ' l l '  i '
rhe ' l ' ( l l { .  Af ier MI'  al l  rats exhibitct l  a sinri lar elcvafion of scrunr t , . ,r1., , , ' - , i , .r  ancl eclLral i .-
fr l rct siz.cs. À'4ortal i ty however, was incrcused in' l ' ( ; l { ,  arrcl A1',  reccl)ror L-r locl<aclc prc-
Verttecl the excess Inortal inr Fronr thc 2 sttrdies rvir lr  rhc' l ' ( lR (cl-. ,"pt. :r  5 e7), i t  i .s c..-
clrrclccl t l rat the lr t 'c l  <tf  N, reccptor cxpression crir icalh, r. .*r-,1.r. ,  ischcmia-relatccl
carcl iac prlranletcrs, both carlv aftcr t l rc iscl-ren-r ic o,cnt, as well  ai. l rrr i ,rg the re'.dcl i .g
Proccss' R$'erse ly, A l ' ,  rcccptor blocl<aclc is ablc to prcvcnr rhc cietr iprcntal cf lècrs ,rf  t l ,c
c levatcc l  Af ,  rcceptor  ex; r rcss ion. ' l .h is  rnay be oÍ rc l in ica l  i rnporrapcc,  s i .ce many c l i . ica l
s l 'ndronres uch l rs  coror lary  nr terv  c l isease r ,v i th  s t t r t tc r ine ischeur ia ,  and le f t  vent r icLr lar
clYsfir l lct ion arc chat 'ectcrizcd bv increascci cxpressirr, ' r  , , f  t l - , .  A'f ,  r-ccc1-rr.r.  Notc*., .rr6r,,
thcse st, t tclrontes al-r ' rr lso associerccl rvi th rrn increrrserl  incicience of iscltcr l ic eveltrs.
I r l  chapter  8 ,  the e f l lcacv o f  genc thcrapy wi th  I )NA cncoc l ing h t rnran VEGF was s f r rc l -
iecl in a nlodel of expcrintental MI in rats. P:rramercrs of IV rer-noclel ipg wcre nro.ir .recl
r ls ot l fcol l le rneasLlres, wir[-r echocarcl i t tql 'aPhv, ancl i tr  thc isolated hcart i '  a 
'erfusio. sct-
trp'  Althotrgl]  thc gctrc therapv lccl to increasecl Vlr( lF gcne erpression ancl increasecl
VI ' .( lF lcvels, no inrProysnlsn5 ()n LV remoclel inq p:rrameters cotr lc, l  bc f irLrncl.
I t t trr trnyocardial clcl iverv of the gene (ancl rhe cc-rnrnrl  t)NA) incrcasccl cor.onary r.esisr_
ar lce '  Poss ib ly  due to  t t ryocard ia l  swcl l ing.  I t  is  spect r la tcc l  that  anorhcr  r i rne po in t ,  la tcr
aftcr MI'  nrav anlel i t l rate [V renroclcl ins, sincc enclogenclr-rs VE(]F lcvels har.e clecl i .ccl
by thetr.  Inf irrct siz-c rvrts l imitecl by VF,( lF therap1,, and this nr:ry also rr l insl:rre inro inr-
provetl  f i rr-rct ion latcr rt f ier MI. l 'his lenrains ro bc shorvn in f irrrLr.c sr,cl ics.
F u't 'u l{ tr  I) IREct-roNS
l \ ' l t t  t r t t r " ts ( .L l tAI i  ( ; l t ( ) \ \ 'n r ,  AN( , r ( )c l :NI ( .  r r ; \CTor ts ,  . {Nr)  nr : , . \ l { f  I jA I r .L j r i t :  ' l 'here is  s t i l l  c le-
bate rvl lether the clecrcrrsc of microvcsscls is c:ulse or consecluencc in hcart fai lure. I t  has
lrccrl  cstrtbl ishecl that ettclothel ial ccl ls, t l r :r t  ' rainlv co.st i t l r te nricrcvesscls,:rre extre'cl ] .
i t r lportr lr- t t  in regtr lat i l tg ntyoc:rrcl ial  f i rnct iu,r.  '1.í-r.  nricrovascular e nclorhcl iurn ucrivclv
en-
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controls thc local circulat ion, and cl irect ly nroclnlates rnyocyte l tunction through local
nrcdiatorsr. Furthennorc, enckrthcl ial  clysf irnct ion (er-rclothel ial c{crrtrclurion with l l ' i ton
X-100) causes dysfr-rnct ion of thc nryocarcl ial  musclr lature, with clecrcascd carcl iac per-
f irrnruncet. ' tb ful ly appreciatc the inrportr 'urcu nricrovrrscular alrnorrnal i t ics in hc:rrr frr i l -
ure, stt-tci ies shourlcl  bc concluctecl that test the effèct of a clecrcased nunrbcr nricrovcssels
on r t ryocurc l ia l  f i rnc t ion.  Adrn in is t ra t ion o f  ant i -ang ioecnic  conrpounc ls  ( l ike  ungio-
s ta t in ' ,  or  synthet ic  r rna logues of  funr i re i l l in ,  l i l<e A( lM-1470 )  coLr lc l  p t r t  th is  in to  c f ïec t ,
whctr tcstcd in nroc' lels thrrt  rrre prorlc to clevclol ' r  heirrt  frr i lurc, such as rr lr  nroclcls lvi th
tyH (SHl{, l {EN2). I t  is hvpothcsizecl that r l ie dccrease in microvessels rvi l l  uccelcratc
thc proercssion to heart fai lr-rre. l f  so, this provicles a rut ionalc fbr thcrapies thar aim ro
restorc rnicrovasclr lar abnorr-nal i t ies in lrcrrrt  [r i lure.
Axt ; rOt ; r :N l :s rs ,  NI r r , r {o l r ( )R.Ni ( )NI :s ,  ANt)  lN I  l { , \ ( . t : i l  L , t .AR s t ( ;N, \ t - lN( ;  I ,R()  I - t : lN. \  l 'h is
thesis clescribes a r l ist inct prl t tcnr of nricrovcssclgrolvth rrncl expression of f ,rctors thrrr nre-
d ia tc  angiogenes is  n  hear t  fa i lu rc . ' l 'h is  pat tcrn  is  character izcd bv a  lack ing micror . 'esse l
growth, that is nrecl iatecl,  anrongst other f irctors, b1, the A1' rcceptor, s\ ' Ínpathetic .sig-
na l ing,  anc l  e lc tncnts  o f  the i t r tmcc l lu lar  s ignr r l ine pathrvu l , . - l 'hc  A l '  rccepror  ves shorvn
to bc associateci r, t , i th krrver nricro'n'cssel numbcrs in t ,HV afier l \ ' i l ,  rrnt l  in h\,pcrtension.
Vt ' ,( ; l -  relcase wrrs not corrclarec' l  with rhe obscrvccl clynrrnrics in nricroi 'esscl gror,vrh, ancl
thcre forc othcr fr ictors l ike henroclynlurt ics, t- tcunrhornronlr l  act ivrrt ion, ancl signel ir .rg crls-
cecles nrrrv bc tnorc i t ' t -r1-rort iurt in his respcct. I t t-uttro, t l -rerc is conrpel l ing cviclcnce that
ncurohortroncs, cspeciel l l '  rurgiotct-rsin I I ,  leacl to upregulrrt ion of rrngioge nic frrctors, ar-rcl
sLtbscqr tc t - r f  r rnu iogcncs is . ' l 'h is  nra l ,go v ia  - t ( iR-P s ignal ing as r . r ,c l l " " ' .  I r t - t , iuo,  neurohor-
nroncs tnay hltvc revcrse ef-fects, 1ls wrrs shor,vn in this thesis. ' l 'hc trcatnrcnt of heart frr i l -
turc Iror,vacleys conlprisc.s an array of neunrhorrnonal inhiLri tors. I t  is hyprothcsizccl f i rr  rhe
2 nrostly usccl t l tcrapics, ACF.-inhibitors ancl beta-bkrckers, thut the cf lect pnrbebll ,  is
prro-engic'r*enic. Af ,  rcceptor blockadc also cxerts pro-angio{enic cffècts ir t- t , íuo. Ftrturc
sttrcl ies houlr l  isolatc aclcl i t ional f i rctors that mcrl iate t l-re rnicrovessel srorvth ancl t l -re re-
leasc of rrtrgiogenic frrctors. Since the observecl cl iscrcl ' r ,rncy bctlveen irt- t , i t tz ant{ i t t-  t , iuo
fnrc l ings (a t  least  when the ro le  oFthc A l '  rcceptor  is  concernec l ) , ; r  f i rc r . rs  shot r lc l  be or . r
(expcrirnental ernd hunran) ir t-uit to str:r l ics. (. learly, thcre is rr nceci for clrrta that explain
thc r l iscrcpancy between in-uítrz ancl ir t- t t iuo cf lccts o1-neurohormonc.s.
]n  the hypcr tcns ivc  set t i l lg ,  thc  re  l : r t ive  cont r ibut ion o f  nr i togcn-r lc t iv i l tcc l  pro te in  k inases
(MAPKs) was st lrdicd, arrcl thc nricrovcssel clensity was f iruncl to bc lnainly rnccl iarec' l  b1,
the extracel lr-r lar signal-relatecl kinasc ( lrRK) rncmbcr of the MAPKs. Knowleclge on the
intracel lulur pathr 'vavs thut cotrfer the ef lècts of neurohorrnonal signal ing l-urs cltr ickly'cx-
panclecl thc last fèw vears ' .  l t  hus become clcar that these pathways ure operative in the
hcart atrd ure rtssociatecl with the dcvelopnrent of carcl iac hypertrophl '  ,  atr ial  f ibr i l lat ion",
rrnd myocarcl i :r l  ischenri:r" ' .  In-uitro, substantial knowlerlge hus becn gathcred on rhe
patlrwavs that nuy cl ircct the expression of engiogenic frrctors. In er.rclothel ial cei ls, epi-
clernral srowth factor (t l ( lF), that is direct ly uf istrci lm of L,Rl(,  is phosprhorylatccl byAT
rcccptor signaling, ar-rcl tlris in turn upregulates VF,GI-. ]t was shor,vn that rrrlzsiue acti-
vu. t io t r  o f  t rRK leads to  s t rons enhanccr l rent  o f  VE( lF gene cxpress ion by mcans of  HIF-
1-dcpenclent pl ' ropsplrorylat ion. This points torvirrcls an im;rort;rnt role of the lrRK s1's-
l l  de-





tem in angiogenesis. In cardiac fibroblasts, a similar pathway is operative, via the AI, re-
ceptor and ERKt'. In-vivo, there are many reports on the MAPK activation in the failing
heart; it remains unknown however whether each cell rypes activate a specific member,
and what the importance is for the pathophysiology.
FurunB THERAPIES? A promising approach would be to use models of cardiac hyper-
trophy with a known enhancement microvessel growth and increase of angiogenic fac-
tors (this is discussed in chapter 2),like exercise-induced and thyreotoxicosis-induced
LVH. These models should be compared to LVH with a decreased microvessel content,
like post-Ml and hypertensive LVH. \íith the use of gene array techniques that are al-
ready operative in cardiovascular researcht'"3, it is feasible to isolate genes that are re-
sponsible for maintenance and growth of microvessels in these distinct hypertrophic
states. The thus-established genes should prompt studies with gene therapy or pharma-
cotherapy.
The use of therapeutic angiogenesis is promising in this respect. Although the study re-
ported in chapter 9 failed to show a beneficial effect, possibly a better timing or reperi-
tive administration would have yielded positive results. Although VEGF is by now the
most used agent, strategies as described above would possibly reveal newer (better)
agents. After MI, the injection of DNA encoding the angiogenic factor (like VEGF) can
be performed in adjacent myocardial tissue, from which the transfected will diffuse to the
ischemic parts ('A little VEGF goes a long *"y'"').
The application of MAPK inhibitors was beneficial with respect to restoring microvessel
growth in LVH. Other parameters of LV remodeling improved as well. This promising
results back up the findings by others, that also showed beneficial effects of MAPK in-
hibitorsr'"5. Future studies should establish the activation pattern of signaling proteins in
heart failure, with a focus on the cell-specific activation. This should allow a targeted
therapy that may yield a full inhibition of the deleterious signal, without an escape phe-
nomenon, as regularly seen in "classical" neurohormonal therapy.
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